Galectin Therapeutics Inc. (GALT)

[biotech2010]

I was referring to the much higher concentration of psoriasis on patient #4 on the legs than the before photos for patients 1 and 2 on their affected areas-they must have psoriasis on a much larger portion of their bodies to have higher initial PASI score-if you look at the Humira before and after photos it's pretty clear (at least to me) that their achievement of PASI 75 was at least partially due to a higher concentration of psoriasis. Dr Traber also referred to this during the conference call on the initial results (that they wanted to enroll patients with more severe psoriasis and at least 1 of the newer patients were at that level).

I'm certainly no psoriasis expert (thankfully) but it's pretty clear from the photos that GR-MD-02 had a positive effect on these people, it's no wonder they all volunteered to continue these treatments.